Diamond Hill Capital Management LLC Investment Advisor bought a new stake in Avantor, Inc. (NYSE:AVTR - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 1,046,390 shares of the company's stock, valued at approximately $10,359,000. Diamond Hill Capital Management LLC Investment Advisor owned approximately 0.15% of Avantor as of its most recent filing with the SEC.
Other large investors have also recently added to or reduced their stakes in the company. Wellington Management Group LLP acquired a new stake in Avantor in the 4th quarter valued at about $268,584,000. Engine Capital Management LP increased its stake in shares of Avantor by 65.8% in the 1st quarter. Engine Capital Management LP now owns 19,780,830 shares of the company's stock valued at $155,082,000 after buying an additional 7,853,018 shares during the period. Morgan Stanley raised its holdings in Avantor by 179.4% during the 4th quarter. Morgan Stanley now owns 17,468,418 shares of the company's stock worth $200,188,000 after purchasing an additional 11,216,565 shares during the last quarter. Invesco Ltd. raised its stake in shares of Avantor by 7.0% during the fourth quarter. Invesco Ltd. now owns 17,178,716 shares of the company's stock worth $196,868,000 after buying an additional 1,125,348 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Avantor by 15.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 16,894,649 shares of the company's stock valued at $132,443,000 after acquiring an additional 2,288,053 shares during the last quarter. 95.08% of the stock is owned by institutional investors.
Avantor Price Performance
Shares of NYSE AVTR opened at $13.52 on Tuesday. The firm has a market cap of $9.14 billion, a P/E ratio of -16.10, a price-to-earnings-growth ratio of 10.29 and a beta of 0.89. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.65. Avantor, Inc. has a 1-year low of $7.26 and a 1-year high of $15.93. The business's 50 day moving average is $11.28 and its 200-day moving average is $9.55.
Avantor (NYSE:AVTR - Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.19 by $0.02. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.61 billion. During the same quarter in the prior year, the business posted $0.24 EPS. The business's revenue was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Equities research analysts predict that Avantor, Inc. will post 0.81 earnings per share for the current year.
Analyst Ratings Changes
Several brokerages have commented on AVTR. Stifel Nicolaus upped their target price on shares of Avantor from $8.00 to $15.00 and gave the company a "hold" rating in a research note on Thursday, July 30th. Barclays increased their target price on Avantor from $7.00 to $8.00 and gave the stock an "underweight" rating in a research note on Wednesday, June 24th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a $13.00 target price on shares of Avantor in a report on Thursday, July 30th. Sanford C. Bernstein assumed coverage on shares of Avantor in a research note on Friday, June 26th. They set a "market perform" rating and a $10.50 price target for the company. Finally, Citigroup lifted their target price on Avantor from $9.00 to $11.00 and gave the company a "neutral" rating in a research report on Wednesday, July 8th. Two research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $12.00.
Check Out Our Latest Analysis on AVTR
Avantor Company Profile
(
Free Report)
Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor's offerings are organized across two primary segments.
Recommended Stories
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.